Conclusions and Clinical Relevance-Results suggested that the perceived shortage of veterinarians in learn more RVP may be in part influenced by a lack of retention, particularly among experienced veterinarians.Targeted efforts to tackle issues related to emergency duty,
time off, salary, practice atmosphere, and family issues could help alleviate the efflux from RVP. (J Am Vet Med Assoc 2010;236:859-8671″
“Objective-To determine whether monthly topical administration of a combination of 10% imidacloprid and 1% moxidectin would lessen flea (Ctenocephalides felis) transmission of Bartonella henselae among cats.
Design-Controlled trial.
Animals-18 specific pathogen-free cats housed in 3 groups of 6.
Procedures-3 enclosures were separated by mesh to allow fleas to pass among groups yet prevent cats from contacting one another. One group was inoculated IV with B henselae, and after infection was confirmed, the cats were housed in the middle enclosure. This infected group was flanked by a group that was treated topically with 10% imidacloprid-1% moxidectin monthly for 3 months and by an untreated group. On days 0, 15,
28, and 42, 100 fleas/cat were placed on each of the 6 cats in the B henselae-infected group. Blood samples were collected from all cats weekly for detection of Bartonella spp via RCA assay, bacterial culture, and serologic assay.
Results-B FDA approved Drug Library clinical trial henselae infection was confirmed in the cats infected IV and in all untreated cats after flea exposure; none of AZD8931 chemical structure the cats treated
with the imidacloprid-moxidectin combination became infected.
Conclusions and Clinical Relevance-In this setting, monthly topical administration of 10% imidacloprid-1% moxidectin reduced flea infestation, compared with infestation in untreated cats, and thus prevented flea transmission of B henselae to treated cats. Regular monthly use of this flea control product in cats may lessen the likelihood of humans acquiring B henselae infection. (J Am Vet Med Assoc 2010;236:869-873)”
“Objective-To evaluate the use of dipstick, sulfosalicylic acid (SSA), and urine protein-to-creatinine ratio (UP:C) methods for use in detection of canine and feline albuminuria.
Design-Evaluation study.
Sample Population-599 canine and 347 feline urine samples.
Procedures-Urine was analyzed by use of dipstick, SSA, and UP:C methods; results were compared with those for a species-specific ELISA to determine sensitivity, specificity, positive predictive value (PPV), negative predictive value, and positive and negative likelihood ratios.
Results-Positive results for dipstick and SSA tests (trace reaction or greater) in canine urine had moderate specificity (dipstick, 81.2%; SSA, 73.3%) and poor PPV (dipstick, 34.0%; SSA, 41.8%). Values improved when stronger positive results(<= 2+) for the dipstick and SSA tests were compared with ELISA results (specificity, 98.9% and 99.